The Global Burden of Cancer 2013
University of Washington · Institute for Health Metrics and Evaluation · +100 more institutions
Abstract
Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.
To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs.
Citation impact
- FWCI
- 166.80
- Percentile
- 100%
- References
- 62
Authors
132- CFChristina FitzmauriceCorresponding
University of Washington, Institute for Health Metrics and Evaluation
- DDDaniel Dicker
University of Washington, Institute for Health Metrics and Evaluation
- APAmanda Pain
University of Washington, Institute for Health Metrics and Evaluation
- HHHannah Hamavid
University of Washington, Institute for Health Metrics and Evaluation
- MMMaziar Moradi‐Lakeh
Iran University of Medical Sciences, Institute for Health Metrics and Evaluation
Topics & keywords
- Medicine
- Cancer
- MEDLINE
- Internal medicine
Funding
- UDU.S. Department of Veterans Affairs
- BABill and Melinda Gates Foundation
- JSJackson State University
- NUNorthwestern University
- HUHarvard University
- PMPhilipps-Universität Marburg
- RPRegeneron Pharmaceuticals
- NUNorthumbria University
- FOFaculty of Medicine, University of British Columbia
- IFInstitute for Health Metrics and Evaluation
- IDIstituto di Ricerche Farmacologiche Mario Negri - IRCCS
- UCUniversity College London
- UOUniversity of Oxford
- ANAustralian National University
- PHPublic Health Foundation of India
- RGRijksuniversiteit Groningen
- JCJames Cook University
- UOUniversity of Queensland
- KHKyung Hee University
- UTUniversiti Tunku Abdul Rahman
- UOUniversity of Hong Kong
- KIKarolinska Institutet
- TUTehran University of Medical Sciences and Health Services
- UIUniversitetet i Bergen
- GUGöteborgs Universitet
- UDUniversità di Bologna
- AUArak University of Medical Sciences
- NRNational Research University Higher School of Economics
- UOUniversity of the Philippines
- AAAddis Ababa University
- MUMekelle University
- NCNational Center of Neurology and Psychiatry
- NINational Institutes of HealthAwards: 5T32HL007093, ES00260
- GGenentech
- AAllergan
- HCHealth Canada
- WUWageningen University and Research
- BABarts and The London School of Medicine and Dentistry
- SASahlgrenska Akademin
- FOFaculty of Medicine and Health, University of Sydney
- UOUniversity of Colorado School of Medicine, Anschutz Medical Campus
- IOInstitute of Infection and Immunity